Business Disruption in a Pandemic: Does COVID-19 Excuse Non-Performance of a Contract
Webinar | 04.02.20, 9:00 AM EDT - 10:00 AM EDT
As COVID-19 rapidly evolves and continues to disrupt your business operations in many ways, companies are increasingly confronting the challenges presented by force majeure and related doctrines in their contracts. Join us for a discussion on the five steps companies should consider as a follow on to the alert we previously shared.
For more information, please visit these areas: Corporate and Transactional
Contact
Participants
Insights
Webinar | 11.17.26
Microplastics: Science, Regulation, and Legal Risk
Microplastics are plastic particles found across the environment—in water supplies, food sources, and human tissue—and have emerged as a frontline legal and regulatory issue. The science is developing quickly, and regulatory and litigation activity is following close behind, from EPA's inclusion of microplastics on its draft Sixth Contaminant Candidate List (CCL 6) as a priority contaminant group to growing state legislation and an expanding wave of private litigation. Companies across industries are facing increasing uncertainty and risk.
Webinar | 11.05.26
